• Associations of IL13 gene polymorphisms and immune factors with Schistosoma haematobium infection in schoolchildren in four schistosomiasis-endemic communities in Ghana 

  Sarpong-Baidoo, M.; Ofori, M. F.; Asuming-Brempong, E. K.; Kyei-Baafour, E.; Idun, B. K.; Owusu-Frimpong, I.; Amonoo, N. A.; Quarshie, Q. D.; Tettevi, E. J.; Osei-Atweneboana, M. Y. (PLOS, 2021)

  Background Schistosomiasis remains a major public health issue with over 90% of the prevalence rates recorded in Sub-Saharan Africa. In this study, the relationships between different interleukin gene polymorphisms ...
• Assessing expanded community wide treatment for schistosomiasis: Baseline infection status and self-reported risk factors in three communities from the Greater Accra region, Ghana 

  Cunningham, L. J.; Campbell, S. J.; Armoo, S.; Koukounari, A.; Watson, V.; Selormey, P.; Stothard, J. R.; Idun, B.; Asiedu, M.; Ashong, Y.; Adams, E. R.; Osei- Atweneboana, M. Y. (PLOS, 2019)

  Background This paper reports on the baseline prevalence and associated risk factor findings of a pilot, longitudinal study exploring community-wide treatment of schistosomiasis and soil-transmitted helminthiasis, using ...
• Genome-wide analysis of ivermectin response by Onchocerca volvulus reveals that genetic drift and soft selective sweeps contribute to loss of drug sensitivity 

  Doyle, S. R.; Bourguinat, C.; Nana-Djeunga, H. C.; Kengne-Ouafo, J. A.; Pion, S. D. S.; Bopda, J.; Kamgno, J.; Wanji, S.; Che, H.; Kuesel, A. C.; Walker, M.; Basáñez, M. G.; Boakye, D. A.; Osei-Atweneboana, M. Y.; Boussinesq, M.; Prichard, R. K.; Grant, W. N. (PLOS, 2017)

  Background Treatment of onchocerciasis using mass ivermectin administration has reduced morbidity and transmission throughout Africa and Central/South America. Mass drug administration is likely to exert selection pressure ...
• Onchocerciasis Transmission in Ghana: Persistence under Different Control Strategies and the Role of the Simuliid Vectors 

  Lamberton, P. H. L.; Cheke, R. A.; Winskill, P.; Tirados, I.; Walker, M.; Osei-Atweneboana, M. Y.; Biritwum, N. K.; Tetteh- Kumah, A.; Boakye, D. A.; Wilson, M. D.; Post, R. J.; Basáñez, M. G. (PLOS, 2015)

  Background The World Health Organization (WHO) aims at eliminating onchocerciasis by 2020 in selected African countries. Current control focuses on community-directed treatment with ivermectin (CDTI). In Ghana, persistent ...
• The Cost of Annual versus Biannual Community-Directed Treatment of Onchocerciasis with Ivermectin: Ghana as a Case Study 

  Turner, H. C.; Osei-Atweneboana, M. Y.; Walker, M.; Tettevi, E. J.; Churcher, T. S.; Asiedu, O.; Biritwum, N. K.; Basáñez, M. G. (PLOS, 2013)

  Background: It has been proposed that switching from annual to biannual (twice yearly) mass community-directed treatment with ivermectin (CDTI) might improve the chances of onchocerciasis elimination in some African foci. ...

View more